|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-9-12
|
|
pubmed:abstractText |
Restrictive cardiomyopathy frequently complicates primary systemic amyloidosis (AL), yet only a small number of these patients develop large pleural effusions refractory to diuretic therapy and thoracentesis. We hypothesized that disruption of pleural function by amyloid deposits underlies persistent pleural effusions (PPEs) in patients with AL disease.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
124
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
969-77
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:12970025-Aged,
pubmed-meshheading:12970025-Amyloidosis,
pubmed-meshheading:12970025-Biopsy, Needle,
pubmed-meshheading:12970025-Cardiomyopathy, Restrictive,
pubmed-meshheading:12970025-Diagnosis, Differential,
pubmed-meshheading:12970025-Echocardiography,
pubmed-meshheading:12970025-Female,
pubmed-meshheading:12970025-Humans,
pubmed-meshheading:12970025-Male,
pubmed-meshheading:12970025-Middle Aged,
pubmed-meshheading:12970025-Myocardium,
pubmed-meshheading:12970025-Pleura,
pubmed-meshheading:12970025-Pleural Effusion,
pubmed-meshheading:12970025-Recurrence,
pubmed-meshheading:12970025-Survival Rate
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.
|
|
pubmed:affiliation |
Amyloid Treatment and Research Program, Department of Medicine, Boston University School of Medicine, Boston, MA, USA. jberk@lung.bumc.bu.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
